What is Ro?
Ro operates as a comprehensive telehealth platform designed to streamline the patient experience through digital connectivity. By offering a seamless interface for consultations and the delivery of FDA-approved medications, the company addresses critical gaps in personal health and wellness. Its market position is defined by a commitment to convenience and affordability, allowing users to manage complex health goals—such as weight management via GLP-1s or fertility support—from their homes. This innovative approach has garnered significant trust, positioning Ro as a leader in the modern healthtech ecosystem.
How much funding has Ro raised?
Ro has raised a total of $1B across 6 funding rounds:
Angel/Seed
$3.1M
Series A
$88M
Series B
$85M
Series C
$200M
Series D
$500M
Unspecified
$150M
Angel/Seed (2017): $3.1M with participation from Initialized Capital, Box Group, General Catalyst, and Slow Ventures
Series A (2018): $88M led by Torch Capital, Initialized Capital, BoxGroup, Slow Ventures, Sinai Ventures, FirstMark Capital, Tusk Ventures, General Catalyst, and SignalFire
Series B (2019): $85M supported by Initialized Capital, FirstMark Capital, Box Group, General Catalyst, and Slow Ventures
Series C (2020): $200M featuring BoxGroup, TQ Ventures, Initialized Capital, FirstMark Capital, General Catalyst, The Chernin Group, 3L, Torch, and SignalFire
Series D (2021): $500M backed by ShawSpring Partners, BoxGroup, The Baupost Group, Altimeter Capital, Dragoneer Investment Group, TQ Ventures, Torch Capital, FirstMark Capital, Radcliff, General Catalyst, 776, and SignalFire
Unspecified (2022): $150M with participation from ShawSpring Partners, FirstMark Capital, and General Catalyst
Key Investors in Ro
General Catalyst
General Catalyst is a venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors, including healthcare and enterprise software.
FirstMark Capital
FirstMark is an early-stage venture capital firm that backs exceptional founders and provides a platform designed to accelerate growth through transformative access to networks and top talent.
Initialized Capital
Initialized Capital is a venture capital firm dedicated to supporting seed-stage founders across various sectors, including health, artificial intelligence, and consumer technology.
What's next for Ro?
Looking ahead, the infusion of capital from the latest round is expected to accelerate Ro's operational scaling and product diversification. As the company matures, the focus will likely shift toward deepening its integration within the broader healthcare infrastructure and enhancing its proprietary technology stack. By maintaining its focus on patient-centric care and leveraging its strong network of institutional backers, Ro is well-positioned to capture further market share in the competitive telehealth landscape. The strategic deployment of these resources will be pivotal in sustaining its growth trajectory and reinforcing its status as a cornerstone of digital health innovation.
See full Ro company page
